<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04081584</url>
  </required_header>
  <id_info>
    <org_study_id>ISS</org_study_id>
    <nct_id>NCT04081584</nct_id>
  </id_info>
  <brief_title>Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering</brief_title>
  <official_title>Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Raydiant Oximetry, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Raydiant Oximetry, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to study light scattering properties of maternal-fetal tissue.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ISS customized commercial frequency domain oximeter is used to obtain light scattering&#xD;
      information from the maternal abdomen for 10-20 minutes preoperatively and postoperatively in&#xD;
      subjects who are having a scheduled C-section.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">June 8, 2021</completion_date>
  <primary_completion_date type="Actual">May 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optical signal from maternal and fetal tissues</measure>
    <time_frame>Peri-operative</time_frame>
    <description>The study of light scattering through maternal/fetal tissue and through maternal tissue alone and newborn tissue alone using a commercial frequency domain oximeter and 2nd generation prototype.</description>
  </primary_outcome>
  <enrollment type="Actual">4</enrollment>
  <condition>Fetal Distress</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ISS Device</intervention_name>
    <description>The ISS Device (commercial and prototype) is used to measure tissue light scattering.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with singleton pregnancies of 36 weeks gestation or more undergoing c-section.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant women with singleton pregnancies, vertex or breech presentation, scheduled&#xD;
             for non-emergent cesarean delivery, including cesarean delivery for failure to&#xD;
             progress with reassuring electronic fetal heart rate tracing&#xD;
&#xD;
          2. Age greater than or equal to 18 years of age.&#xD;
&#xD;
          3. Healthy women at equal to or greater than 36 weeks gestation undergoing non-emergency&#xD;
             cesarean delivery&#xD;
&#xD;
          4. Spinal or epidural anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Emergency cesarian delivery&#xD;
&#xD;
          2. Non-reassuring fetal heart rate tracing&#xD;
&#xD;
          3. Less than 18 years of age&#xD;
&#xD;
          4. Multiple gestation (twins, triplets)&#xD;
&#xD;
          5. Presentation other than vertex or breech&#xD;
&#xD;
          6. Less than 36 weeks of gestation&#xD;
&#xD;
          7. General anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing a C-Section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2019</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Distress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

